Related Experiment Videos

Paediatric Collagenous Gastritis with Transient Response to Steroid Therapy

Rónán O'Connor1, Richard Standish2,3, Hirannya Karunadasa1

  • 1Department of Gastroenterology, Eastern Health, Melbourne, Victoria, Australia.

Insights

Collagenous gastritis, a rare condition, can cause iron deficiency anemia in young females. While corticosteroids may offer temporary relief, sustained remission of this rare gastric disorder remains challenging.

Area of Science:

  • Gastroenterology
  • Pathology

Background:

  • Collagenous gastritis is a rare disorder characterized by subepithelial collagen deposition and inflammation.
  • Its pathogenesis is poorly understood, with limited evidence guiding treatment strategies.

Purpose of the Study:

  • To report a case of pediatric collagenous gastritis presenting with iron deficiency anemia.
  • To highlight diagnostic and management challenges associated with this rare condition.

Main Methods:

  • Case report of a pediatric patient with dyspepsia, nausea, and iron deficiency anemia.
  • Diagnostic workup included endoscopy with nodular gastritis findings and histological confirmation.
  • Treatment involved budesonide with initial symptomatic improvement.

Main Results:

  • Histological examination confirmed collagenous gastritis.
  • Budesonide provided temporary symptomatic relief but was not sustained.
  • The case underscores the difficulty in achieving sustained clinical or histological remission.

Conclusions:

  • Collagenous gastritis should be considered in young patients with unexplained iron deficiency anemia and gastrointestinal symptoms.
  • Endoscopy is crucial for diagnosing alternative causes of iron deficiency beyond menstruation.
  • Current treatment options, including corticosteroids, offer variable efficacy and transient improvement.
Abstract

Related Concept Videos

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...